Zynex Inc Ár/értékesítés
Mi az Zynex Inc Ár/értékesítés?
A Ár/értékesítés az Zynex Inc - 2.76
Mi a Ár/értékesítés meghatározása?
Az ár / árbevétel arány a vállalat részvényeinek árbevételéhez képest.
The price to sales ratio, Price/Sales ratio, P/S ratio, or PSR, is a valuation metric for stocks. It is calculated by dividing the company's market cap by the revenue in the most recent year. It can also be calculated by dividing the per-share stock price by per-share revenue. The price to sales ratio is for trailing twelve months so the reported sales are for the four previous quarters. Longer time periods can be examined at times.
A smaller price to sales ratio is usually thought to be a better investment since the investor is paying less for each unit of sales. However, sales do not reveal the whole picture, as the company may be unprofitable with a low P/S ratio. Because of the limitations, this ratio is usually used only for unprofitable companies, since they don't have a price to earnings ratio (P/E ratio). The metric can be used to determine the value of a stock relative to its past performance. It may also be used to determine relative valuation of a sector or the market as a whole.
Price to sales ratios vary greatly between sectors, so they are most useful in comparing similar stocks within a sector or sub-sector. Comparing P/S ratios carries the implicit assumption that all firms in the comparison have an identical capital structure.
Ár/értékesítés a Health Care szektor a NASDAQ-on cégekben a Zynex Inc -hoz képest
Mit csinál Zynex Inc?
zynex, inc. founded in 1996, engineers, manufactures and markets neuro-diagnostics, stroke rehabilitation, pain management and cardiac monitoring devices within three subsidiaries. zynex medical is a provider of electrotherapy products for home use. zynex monitoring solutions develops products for cardiac monitoring for use in hospitals. zynex neurodiagnostics develops devices for emg and eeg diagnostic applications within neurology disciplines. zynex medical's product line is fully developed, fda/ce cleared, commercially sold, and has been developed to uphold the company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. zynex monitoring solutions and zynex neurodiagnostics are currently both in the development stages without any significant revenues.
ár/értékesítés -hoz hasonló cégek Zynex Inc
- Service International nak Ár/értékesítés 2.76 van
- Harworth Plc nak Ár/értékesítés 2.76 van
- Castrol India nak Ár/értékesítés 2.76 van
- Republic Services nak Ár/értékesítés 2.76 van
- Castrol India nak Ár/értékesítés 2.76 van
- Marriott International nak Ár/értékesítés 2.76 van
- Zynex Inc nak Ár/értékesítés 2.76 van
- Recon Technology Ltd nak Ár/értékesítés 2.76 van
- Riskified nak Ár/értékesítés 2.76 van
- Tortoise Midstream Fund Inc nak Ár/értékesítés 2.76 van
- HealthCare Global Enterprises nak Ár/értékesítés 2.76 van
- The Karur Vysya Bank nak Ár/értékesítés 2.76 van
- CSPC Pharmaceutical nak Ár/értékesítés 2.76 van